My Top 2 Recent Tech IPOs to Buy for May 2026

Circle and CoreWeave are highlighted as two successful recent tech IPOs, with Circle's stock more than quadrupling from its $31 IPO price and CoreWeave nearly tripling from its $40 IPO price. Circle is expected to benefit from growing stablecoin issuance and 2025-2028 revenue/EBITDA CAGRs of 26% and 32%, while CoreWeave's AI infrastructure business is expanding rapidly with $99.4B of backlog and projected 97% revenue CAGR through 2028. The article is constructive on both names, though it notes regulatory risk for stablecoin yields and CoreWeave's heavy debt load.

Analysis

The cleaner read-through is that both names are monetizing scarcity, not just growth. CRCL is a tollbooth on dollar liquidity, but the more important second-order effect is that any regulatory cap on passive yields could push usage from consumer savings behavior toward transaction rails and business APIs, which is structurally better for take-rate stability even if headline minting slows. That makes the market’s obsession with reserve income a bit myopic: the real durability comes from embedded distribution into payment flows, not from hoarding balances.

CRWV is more cyclical than the multiple implies because its economics depend on GPU financing spreads staying wide enough to justify aggressive leverage. The incremental winner isn’t only CoreWeave; it’s NVDA, which effectively gets a demand call option on every new data-center buildout, while larger cloud platforms face an uncomfortable choice between matching price/performance or letting a specialist keep the high-utilization AI workloads. The competitive pressure will likely show up first in capex budgets at MSFT and META over the next 2-4 quarters, where internal build-vs-buy decisions matter more than near-term revenue share.

The contrarian issue is that both narratives can be right and still underwhelm if the market is discounting too much normalization too early. For CRCL, the risk window is legislative and can re-rate the stock in days if yield restrictions are broadened; for CRWV, the risk window is months, as backlog quality and counterparty concentration will be tested if AI deployment schedules slip or financing becomes less forgiving. The consensus is underpricing the financing and policy fragility embedded in both stories, especially where leverage and regulation are the real bottlenecks rather than demand.

In short, this is a momentum-positive setup, but not a clean quality-growth pair: one is a policy-sensitive financial infrastructure play, the other a levered infrastructure landlord for AI compute. The best risk/reward is to own the structural beneficiaries and fade the most crowded assumptions around perpetual margin expansion and benign regulation.

Key Decisions for Investors

• Long CRWV vs short a basket of hyperscaler cloud proxies (MSFT/META) over 3-6 months: the specialist should keep capturing the highest-marginal AI workloads while incumbents absorb capex drag; stop if hyperscaler capex guides materially re-accelerate.
• Buy NVDA on weakness tied to AI infra skepticism, 1-3 month horizon: every additional CoreWeave-style deployment is downstream GPU demand with superior risk/reward versus owning the levered operator; use pullbacks as entries.
• Avoid initiating fresh CRCL longs ahead of legislative headlines; if already long, reduce into strength and consider downside hedges via put spreads for the next 30-90 days, since the biggest downside catalyst is policy, not fundamentals.
• For aggressive accounts: pair long CRCL / short lower-quality payment or fintech exposure only if the market sells off on regulation noise; the relative winner is the platform with direct reserve economics and API optionality, but size small due to headline risk.
• If CRWV rerates above current implied EBITDA multiples without an update on financing terms or customer concentration, take partial profits: the setup is attractive, but leverage makes the equity vulnerable to any 1-2 quarter slowdown in backlog conversion.